Composition
- Active ingredients
- ETHOSUXIMIDE 250MG/5ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ETHOSUXIMIDE 250MG · CapsuleANDA210654-001 · Prescription
- ETHOSUXIMIDE 250MG · CapsuleANDA200892-001 · Discontinued
- ETHOSUXIMIDE 250MG/5ML · SyrupANDA040506-001 · Prescription
- ETHOSUXIMIDE 250MG · CapsuleANDA040430-001 · Prescription
- ETHOSUXIMIDE 250MG · CapsuleANDA211928-001 · Prescription
- ETHOSUXIMIDE 250MG/5ML · SyrupANDA081306-001 · Discontinued
- ETHOSUXIMIDE 250MG · CapsuleANDA040686-001 · Prescription
- ETHOSUXIMIDE 250MG/5ML · SyrupThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA040253.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Ethosuximide
- Route
- Oral
- Dosage form
- Syrup
- Applicant
- Pharm Assoc
- Status
- Prescription
- FDA approval
- 22 Nov 2000
- Application
- ANDA040253-001